Regulation Drugs or non-drug alternatives: how should we treat chronic primary pain in the UK? 23 Nov 2020
23 Nov 2020 Uncategorised AstraZeneca’s Covid-19 vaccine achieves up to 90% interim efficacy 23 Nov 2020
23 Nov 2020 Analysis Drugs or non-drug alternatives: how should we treat chronic primary pain in the UK? 23 Nov 2020
23 Nov 2020 Uncategorised Coronavirus company news summary – Regeneron’s antibody cocktail receives EUA from FDA – Pfizer and BioNTech submit EUA to the FDA for Covid-19 vaccine 23 Nov 2020
19 Nov 2020 Uncategorised University of Oxford reports promising results in older adults in Phase II vaccine trial 19 Nov 2020
19 Nov 2020 Uncategorised Coronavirus company news summary – Pfizer, BioNTech to file for EUA in the US for Covid-19 vaccine – Relief Therapeutics finds partners for European clinical trials of RLF-100 19 Nov 2020
18 Nov 2020 Analysis Spotlight on Zolgensma: REGENXBIO receives $80m from Novartis for AAV vector 18 Nov 2020
18 Nov 2020 Analysis Calliditas takes control of Genkyotex: expanding the rare disease pipeline 18 Nov 2020
18 Nov 2020 Uncategorised Coronavirus company news summary – FDA to be transparent about EUA process for Covid-19 drugs and vaccines – Moderna signs supply deal with the UK 18 Nov 2020
